Related Experiment Video
Updated: May 24, 2026
07:56
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
Carbetocin for preventing postpartum haemorrhage
Lin-Lin Su1, Yap-Seng Chong, Miny Samuel
1Department ofObstetrics andGynaecology, Yong Loo Lin School ofMedicine,NationalUniversity of Singapore, Singapore, Singapore. obgsll@nus.edu.sg.
The Cochrane Database of Systematic Reviews
|February 17, 2012
Summary
Carbetocin, an oxytocin agonist, effectively prevents postpartum hemorrhage (PPH) in women undergoing cesarean deliveries and reduces blood loss and adverse effects in vaginal deliveries compared to syntometrine. Further research is needed on its cost-effectiveness.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Maternal Health
Background:
- Postpartum hemorrhage (PPH) is a leading cause of maternal mortality and morbidity globally.
- Active management of the third stage of labor is crucial for PPH prevention.
- Carbetocin, a long-acting oxytocin agonist, shows promise for PPH prevention.
Purpose of the Study:
- To evaluate the efficacy of oxytocin agonists (carbetocin) versus conventional uterotonics for PPH prevention.
- To assess optimal administration routes and dosages for oxytocin agonists.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) comparing carbetocin with other uterotonics or placebo.
- Searches conducted in Cochrane, MEDLINE, and EMBASE databases up to March 2011.
- Independent data extraction and risk of bias assessment by two reviewers.
Main Results:
- Carbetocin significantly reduced the need for therapeutic uterotonics compared to oxytocin in cesarean deliveries.
- Carbetocin was associated with reduced blood loss and fewer adverse effects (nausea, vomiting, hypertension) compared to syntometrine in vaginal deliveries.
- Carbetocin reduced the need for uterine massage in both cesarean and vaginal deliveries compared to oxytocin.
Conclusions:
- Intravenous carbetocin (100 µg) appears more effective than oxytocin for PPH prevention in cesarean deliveries, though more studies are needed.
- Carbetocin demonstrates benefits over syntometrine in vaginal deliveries, including reduced blood loss and fewer side effects.
- Further research is required to determine the cost-effectiveness of carbetocin as a uterotonic agent.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...